Kenneth W. O'Keefe, Director at Jazz Pharmaceuticals plc (JAZZ), sold 2,612 shares at $147.96 ($386K) on 2021-08-06, disclosed to the SEC on 2021-08-10.
Seasonal sale ($386k) by Director — this insider has traded JAZZ in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $147.96 | 1,306 | $193K | 50.0% |
| 2 | $147.96 | 1,306 | $193K | 50.0% |
| Total | $147.96 avg | 2,612 | $386K | 100% |
| Filing → |
| JAZZ | SELL | 2022-08-09 | $332K | — | Filing → |
| JAZZ | SELL | 2020-11-09 | $3.4M | — | Filing → |
| JAZZ | SELL | 2020-08-10 | $234K | — | Filing → |